Mortality and loss to follow-up among HAART initiators in rural South Africa
- 1 June 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 103 (6) , 588-593
Abstract
A retrospective cohort study of mortality rates and potential predictors of death was conducted in public-sector patients initiating highly active antiretroviral therapy (HAART) between October 2005 and September 2007 in a rural, under-resourced region of South Africa. The aims were to determine the relative contribution of death to cohort exit and the causes and predictors of mortality among HAART initiators. A community outreach programme traced non-attenders. Patients categorised as dying at home underwent a verbal autopsy (by interviewing family members) and case-file review, and those dying in hospital a case-file review, to determine the probable cause of death. At 24 months 1131 (83.6%) patients were retained on treatment in the programme, 124 (9.2%) had died, 63 (4.7%) had transferred out, and 35 (2.6%) were lost to follow-up. The most common causes of death were tuberculosis (44.3%) and diarrhoeal diseases (24.5%). Death was the major reason for cohort exit. As experience is gained with rural HAART programmes mortality rates may decrease. These results draw attention to the need for early HIV diagnosis, increased access to HAART services with earlier treatment initiation, and routine screening and aggressive management of opportunistic infections, particularly tuberculosis. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.Keywords
This publication has 22 references indexed in Scilit:
- Implementing Antiretroviral Therapy in Rural Communities: The Lusikisiki Model of Decentralized HIV/AIDS CareThe Journal of Infectious Diseases, 2007
- Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic ReviewPLOS Medicine, 2007
- Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and FacilitatorsPLOS Medicine, 2006
- Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program EvaluationClinical Infectious Diseases, 2006
- Predictors of early death in a cohort of Ethiopian patients treated with HAARTBMC Infectious Diseases, 2006
- Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort studyAIDS, 2006
- Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesThe Lancet, 2006
- How Can Earlier Entry of Patients into Antiretroviral Programs in Low-Income Countries Be Promoted?Clinical Infectious Diseases, 2006
- Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme designAIDS, 2005
- Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South AfricaAIDS, 2004